Immunovant (IMVT) Invested Capital (2019 - 2023)
Immunovant (IMVT) posted Invested Capital of $350000.0 for Q1 2023, up 104.68% on a QoQ basis from $171000.0 in Q1 2022, and up 104.68% year-over-year from $171000.0 in Q1 2022.
Immunovant (IMVT) Invested Capital (2019 - 2023) Analysis & Trends
Immunovant's Invested Capital history runs 4 years deep, the most recent figure standing at $350000.0 for Q1 2023.
- Quarterly Invested Capital rose 104.68% year-over-year to $350000.0 in Q1 2023, while the trailing twelve-month figure through Dec 2023 was $350000.0 (up 104.68% YoY) and the FY2023 annual result came in at $350000.0, up 104.68% from the prior year.
- Invested Capital was $350000.0 for Q1 2023 at Immunovant, up from $171000.0 in the prior quarter.
- Across five years, Invested Capital topped out at $5.0 million in Q2 2019 and bottomed at $58000.0 in Q1 2019.
- A 4-year average of $1.7 million and a median of $350000.0 in 2023 frame the typical range for Invested Capital.
- Peak annual rise in Invested Capital reached 5400.0% in 2020, while the deepest fall reached 94.64% in 2020.
- Immunovant's Invested Capital stood at $3.1 million in 2019, then tumbled by 95.72% to $134000.0 in 2020, then gained by 27.61% to $171000.0 in 2022, then jumped by 104.68% to $350000.0 in 2023.
- Business Quant data shows IMVT's Invested Capital at $350000.0 in Q1 2023, $171000.0 in Q1 2022, and $134000.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 116.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Immunovant | 7.18 Bn | 7.18 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 350,000.00 |
| Mar 31, 2022 | 171,000.00 |
| Sep 30, 2020 | 134,000.00 |
| Jun 30, 2020 | 336,000.00 |
| Mar 31, 2020 | 3.19 Mn |
| Dec 31, 2019 | 3.13 Mn |
| Sep 30, 2019 | 2.50 Mn |
| Jun 30, 2019 | 5.00 Mn |
| Mar 31, 2019 | 58,000.00 |